Results 91 to 100 of about 2,138 (143)

Design, Synthesis, and Evaluation of Novel Thiazole-Based Peptidomimetic Compounds as Potent SARS-CoV-2 Main Protease Covalent Inhibitors. [PDF]

ACS Infect Dis
Yin W, Kong WP, Leung SL, Liang Z, Chen YW, Wong KY.   +5 more
europepmc   +1 more source

First-year Experience with Brivaracetam in Japan: Real-world Data from Juntendo Epilepsy Center. [PDF]

Neurol Med Chir (Tokyo)
Iimura Y, Nomura K, Mitsuhashi T, Suzuki H, Ueda T, Nishioka K, Tsunemi T, Ueno S, Sugano H, Kondo A.   +9 more
europepmc   +1 more source

Development and validation of a HPLC method for therapeutic monitoring of brivaracetam. [PDF]

Biochem Med (Zagreb)
Komljenović S, Zovko S, Bujan Kovač A, Petelin Gadže Ž, Sertić M, Lovrić M.   +5 more
europepmc   +1 more source

Imaging Microtubule Dynamics In Vivo in Human Brain: Optimal Quantification Based on a Test-Retest Study. [PDF]

J Nucl Med
Zanderigo F, Laurell GL, Doubrovin M, Molotkov A, Ali A, Arevalo RF, Solingapuram Sai KK, Mann JJ, Mintz A.   +8 more
europepmc   +1 more source

Enhancing bone repair ability of 3D-printed PLLA scaffolds via N-methyl-2-pyrrolidone etching. [PDF]

J Mater Sci Mater Med
Yuanzheng W, Qilin J, Xin H, Shaohong W, Jinlong L, Jian C, Zhongxing L.   +6 more
europepmc   +1 more source

A Phase 1 Multiple-Dose, Open-Label, Pharmacokinetic Study of Nirmatrelvir/Ritonavir in Healthy Lactating Women. [PDF]

Clin Transl Sci
Gerhart J, Cheruvu N, Pelletier K, Matschke K, Shi H, Mfopou JK, Hammond J, Singh RSP.   +7 more
europepmc   +1 more source

Efficacy and Safety of Envafolimab Combined With Capecitabine and Lenvatinib as Postoperative Adjuvant Therapy in Resected Biliary Tract Cancer With High-Risk Recurrence Factors: A Phase II Single-Center Prospective Study. [PDF]

Cancer Med
Tian Y, Lei T, Ruan Q, Zhou X, Shen R, Xie T, Li S, Cai X, Chen M.   +8 more
europepmc   +1 more source

Synthesis of γ‑Lactams by Intermolecular (3 + 2) Annulation of Siloxy Alkynes and 3‑Aminooxetanes. [PDF]

Precis Chem
Li X, Feng Q, Liu S, Huang H, Han Z, Sun J.   +5 more
europepmc   +1 more source

The Epilepsy-Desirability of Outcome Ranking (DOOR) as a Multi-Faceted Consumer-Informed Outcome Measure for Epilepsy Clinical Trials. [PDF]

Eur J Neurol
Vivash L, Johns H, O Brien TJ, Churilov L.   +3 more
europepmc   +1 more source

Reassessing the adverse event profiles of levetiracetam and brivaracetam: a systematic review and meta-analysis. [PDF]

J Neurol
Fröling E, Morales Sahm M, Schmude M, Assies CP, Wittenberg M, Rosenow F, Bermpohl F, Riemer TG.   +7 more
europepmc   +1 more source